Compare INNV & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INNV | CYRX |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 421.6M |
| IPO Year | 2021 | 2008 |
| Metric | INNV | CYRX |
|---|---|---|
| Price | $8.88 | $8.10 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $7.00 | ★ $12.94 |
| AVG Volume (30 Days) | ★ 397.5K | 341.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | 0.14 | ★ 1.40 |
| Revenue | ★ $853,699,000.00 | $176,177,000.00 |
| Revenue This Year | $12.82 | $9.71 |
| Revenue Next Year | $9.22 | $9.56 |
| P/E Ratio | $67.57 | ★ $4.99 |
| Revenue Growth | ★ 11.76 | N/A |
| 52 Week Low | $2.60 | $4.63 |
| 52 Week High | $10.69 | $11.45 |
| Indicator | INNV | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.05 | 37.26 |
| Support Level | $5.01 | $6.57 |
| Resistance Level | $9.18 | $8.45 |
| Average True Range (ATR) | 0.77 | 0.51 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 39.59 | 25.71 |
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.